Home » Newsletters » BioWorld

BioWorld

Aug. 19, 1993

View Archived Issues

CEPHALON INITIATES U.S. TRIALS OF MODAFINIL

ASSURANCES OF NO MANDATORY DRUG PRICE CONTROLS

HYBRIDON LICENSES ANTISENSE PATENTS

MITSUBISHI TO MARKET METAMOUSE IN JAPAN

COURT SUPPORTS REPLIGEN PATENT

PERSEPTIVE GETS IMMUNOASSAY PATENT

RESEARCH SUPPORTS MABS AS CANCER FIGHTERS

UNIVAX BEGINS VACCINE TRIALS

HARRIER RECEIVES NOTICE FOR PATENT

DDI BEGINS STUDIES ON ANTI-OXIDANTS

CELLPRO READY TO START TRIALS

NEW VERSION OF BIOSYS INSECTICIDE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...